Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin added to concurrent chemoradiation for head and neck squamous cell carcinoma
IRCT20191203045594N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metformin in laryngeal squamous cell carcinoma (LSCC), squamous cell carcinoma of the hypopharynx and nasopharyngeal squamous cell carcinoma, sponsored by Shiraz University of Medical Sciences. Primary endpoint: Complete response on spiral CT scan. Started Dec 2019; status: completed.
02
Drugs
metformin
03
Conditions
laryngeal squamous cell carcinoma (LSCC)squamous cell carcinoma of the hypopharynxnasopharyngeal squamous cell carcinoma
Beyond the preview
Go deeper on IRCT20191203045594N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191203045594N1.